Drugs / CD8+ Memory T Cell Infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04151706 | Feb 2020 → Sep 2023 | acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome | Robert Lowsky | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD8+ Memory T Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04151706 ↗ |
| Modality | Cell therapy | “Allogeneic phenotypic CD8+ memory T cells from HLA matched donors infused at the time of hematopoietic cell transplantation” NCT04151706 ↗ |